145 related articles for article (PubMed ID: 1819866)
1. [Colicinogeny in nonspecific intestinal inflammations and colorectal cancer].
Bures J; Horák V; Tichý M; Pidrman V; Jandík P; Fixa B; Komárková O
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1991; 34(3):349-403. PubMed ID: 1819866
[TBL] [Abstract][Full Text] [Related]
2. Colicinogeny in colorectal cancer.
Bures J; Horák V; Fixa B; Komárková O; Zaydlar K; Lonský V; Masurka V
Neoplasma; 1986; 33(2):233-7. PubMed ID: 3520352
[TBL] [Abstract][Full Text] [Related]
3. Incidence of colicinogenic strains among human Escherichia coli.
Smarda J; Obdrzálek V
J Basic Microbiol; 2001; 41(6):367-74. PubMed ID: 11802547
[TBL] [Abstract][Full Text] [Related]
4. Colicinogeny in chronic inflammatory bowel disease.
Bures J; Horák V; Buresová E; Fixa B; Komárková O; Hartmann M
Scand J Gastroenterol; 1986 Sep; 21(7):819-23. PubMed ID: 3535009
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
6. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
8. Assessment of resistance to colicinogenic Escherichia coli by E. coli O157:H7 strains.
Schamberger GP; Diez-Gonzalez F
J Appl Microbiol; 2005; 98(1):245-52. PubMed ID: 15610438
[TBL] [Abstract][Full Text] [Related]
9. Importance of colicinogeny for the course of acute bacillary dysentery.
Bures J; Horák V; Duben J
Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):469-75. PubMed ID: 44941
[TBL] [Abstract][Full Text] [Related]
10. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
12. Plasmid profile, colicinogeny and phage sensitivity as indicators of the dynamics of Escherichia coli populations in the human gut.
Burova LM; Korneichuk EP; Kushkina AI; Tovkach FI
Mikrobiol Z; 2012; 74(5):99-107. PubMed ID: 23120990
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of colicin and hemolysins in Escherichia coli isolated from pregnant patients with urinary tract infection, symptomatic and asymptomatic].
Arriaga-Alba M; Rivera Sánchez R; Romero Díaz G; Hernando Aguilar N; García Jiménez E; Flores Paz R
Ginecol Obstet Mex; 2000 Jul; 68():275-81. PubMed ID: 11006640
[TBL] [Abstract][Full Text] [Related]
14. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
15. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in the frequency of colicinogeny in Escherichia coli from house mice.
Gordon DM; Riley MA; Pinou T
Microbiology (Reading); 1998 Aug; 144 ( Pt 8)():2233-2240. PubMed ID: 9720045
[TBL] [Abstract][Full Text] [Related]
17. [Using the laboratory strains of Escherichia coli for studying colicinogenicity].
Burova LM; Tovkach FI; Kushkina AI; Britskaia VS
Mikrobiol Z; 2010; 72(4):49-55. PubMed ID: 20812511
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia.
Kohoutova D; Smajs D; Moravkova P; Cyrany J; Moravkova M; Forstlova M; Cihak M; Rejchrt S; Bures J
BMC Infect Dis; 2014 Dec; 14():733. PubMed ID: 25540872
[TBL] [Abstract][Full Text] [Related]
20. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
